Overview

Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia

Status:
Recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
To assesse the efficacy and safety of luspatercept versus placebo in China patients with transfusion-dependent β-thalassaemia.
Phase:
N/A
Details
Lead Sponsor:
Hematology department of the 920th hospital
Treatments:
Luspatercept